Department of Emergency Medicine, The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, USA; Department of Epidemiology, Brown University School of Public Health, 55 Claverick St., 2nd floor, Providence, RI 02903, USA.
Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Int J Drug Policy. 2020 Mar;77:102661. doi: 10.1016/j.drugpo.2020.102661. Epub 2020 Jan 14.
Fentanyl has caused rapid increases in US and Canadian overdose deaths, yet its presence in illicit drugs is often unknown to consumers. This study examined the validity in identifying the presence of fentanyl of three portable devices that could be used in providing drug checking services and drug supply surveillance: fentanyl test strips, a hand-held Raman Spectrometer, and a desktop Fourier-Transform Infrared Spectrometer.
In Fall 2017, we first undertook an assessment of the limits of detection for fentanyl, then tested the three devices' sensitivity and specificity in distinguishing fentanyl in street-acquired drug samples. Utilizing test replicates of standard fentanyl reference material over a range of increasingly lower concentrations, we determined the lowest concentration reliably detected. To establish the sensitivity and specificity for fentanyl, 210 samples (106 fentanyl-positive, 104 fentanyl-negative) previously submitted by law enforcement entities to forensic laboratories in Baltimore, Maryland, and Providence, Rhode Island, were tested using the devices. All sample testing followed parallel and standardized protocols in the two labs.
The lowest limit of detection (0.100 mcg/mL), false negative (3.7%), and false positive rate (9.6%) was found for fentanyl test strips, which also correctly detected two fentanyl analogs (acetyl fentanyl and furanyl fentanyl) alone or in the presence of another drug, in both powder and pill forms. While less sensitive and specific for fentanyl, the other devices conveyed additional relevant information including the percentage of fentanyl and presence of cutting agents and other drugs.
Devices for fentanyl drug checking are available and valid. Drug checking services and drug supply surveillance should be considered and researched as part of public health responses to the opioid overdose crisis.
芬太尼已导致美国和加拿大的过量用药死亡人数迅速增加,但其在非法药物中的存在往往不为消费者所知。本研究检验了三种便携式设备(芬太尼检测条、手持式拉曼光谱仪和台式傅里叶变换红外光谱仪)在识别芬太尼存在方面的有效性,这些设备可用于提供药物检测服务和药物供应监测。
2017 年秋季,我们首先评估了芬太尼的检测极限,然后测试了这三种设备在区分街头获取的药物样本中芬太尼的灵敏度和特异性。我们利用标准芬太尼参考物质的测试重复样本,在一系列浓度逐渐降低的范围内,确定了可可靠检测到的最低浓度。为了确定芬太尼的灵敏度和特异性,我们使用这些设备对马里兰州巴尔的摩和罗得岛州普罗维登斯的执法机构先前提交给法医实验室的 210 个样本(106 个芬太尼阳性,104 个芬太尼阴性)进行了测试。两个实验室均按照平行和标准化的协议进行所有样本测试。
芬太尼检测条的最低检测极限(0.100 mcg/mL)、假阴性率(3.7%)和假阳性率(9.6%)最低,并且还正确地检测到两种芬太尼类似物(乙酰芬太尼和呋喃芬太尼),无论是单独存在还是与另一种药物一起存在,无论是粉末形式还是丸剂形式。虽然对芬太尼的灵敏度和特异性较低,但其他设备提供了其他相关信息,包括芬太尼的百分比以及是否存在切割剂和其他药物。
芬太尼药物检测设备已经可用且有效。药物检测服务和药物供应监测应作为应对阿片类药物过量危机的公共卫生应对措施的一部分进行考虑和研究。